Low levels of PCSK9 are associated with remission in patients with rheumatoid arthritis treated with anti-TNF-α: potential underlying mechanisms

Low levels of PCSK9 are associated with remission in patients with rheumatoid arthritis treated with anti-TNF-α: potential underlying mechanisms

Abstract Background Proprotein convertase subtilisin kexin 9 (PCSK9) targets the LDL-receptor (LDLR) which raises LDL-levels. In addition, PCSK9 has proinflammatory immunological effects. Here, we investigate the role of PCSK9 in relation to the inflammatory activity in patients with rheumatoid arth...

Full description

Bibliographic Details
Main Authors: Johan Frostegård, Sabbir Ahmed, Ingiäld Hafström, Sofia Ajeganova, Mizanur Rahman
Format: Article
Language:English
Published: BMC 2021-01-01
Series:Arthritis Research & Therapy
Subjects:
Proprotein convertase subtilisin kexin 9 (PCSK9)
Rheumatoid arthritis
Disease activity
Tumor necrosis factor (TNF)
Macrophages
Synoviocytes
Online Access:https://doi.org/10.1186/s13075-020-02386-7

Internet

https://doi.org/10.1186/s13075-020-02386-7

Similar Items